128 related articles for article (PubMed ID: 35573730)
1. Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.
Scala MC; Di Micco S; Lanzillotta D; Musella S; Di Sarno V; Parrino B; Cascioferro SM; Bifulco G; Trapasso F; Campiglia P; Sala M
Front Mol Biosci; 2022; 9():915838. PubMed ID: 35573730
[TBL] [Abstract][Full Text] [Related]
2. Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.
Scala MC; Di Micco S; Lanzillotta D; Musella S; Di Sarno V; Parrino B; Casciofierro SM; Bifulco G; Trapasso F; Campiglia P; Sala M
Front Mol Biosci; 2021; 8():715263. PubMed ID: 34901149
[TBL] [Abstract][Full Text] [Related]
3. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
Gaudio E; Paduano F; Ngankeu A; Ortuso F; Lovat F; Pinton S; D'Agostino S; Zanesi N; Aqeilan RI; Campiglia P; Novellino E; Alcaro S; Croce CM; Trapasso F
Oncotarget; 2016 May; 7(21):29927-36. PubMed ID: 27166255
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: The disease associated Tau35 fragment has an increased propensity to aggregate compared to full-length tau.
Lyu C; Da Vela S; Al-Hilaly Y; Marshall KE; Thorogate R; Svergun D; Serpell LC; Pastore A; Hanger DP
Front Mol Biosci; 2023; 10():1276677. PubMed ID: 37790876
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke.
Eyford BA; Singh CSB; Abraham T; Munro L; Choi KB; Hill T; Hildebrandt R; Welch I; Vitalis TZ; Gabathuler R; Gordon JA; Adomat H; Guns EST; Lu CJ; Pfeifer CG; Tian MM; Jefferies WA
Front Mol Biosci; 2021; 8():687587. PubMed ID: 34026851
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.
Kim A; Enomoto T; Serada S; Ueda Y; Takahashi T; Ripley B; Miyatake T; Fujita M; Lee CM; Morimoto K; Fujimoto M; Kimura T; Naka T
Int J Cancer; 2009 Nov; 125(10):2316-22. PubMed ID: 19598262
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
[TBL] [Abstract][Full Text] [Related]
8. Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.
Kim A; Serada S; Enomoto T; Naka T
Expert Opin Ther Targets; 2010 Sep; 14(9):963-71. PubMed ID: 20673185
[TBL] [Abstract][Full Text] [Related]
9. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.
Gaudio E; Paduano F; Spizzo R; Ngankeu A; Zanesi N; Gaspari M; Ortuso F; Lovat F; Rock J; Hill GA; Kaou M; Cuda G; Aqeilan RI; Alcaro S; Croce CM; Trapasso F
PLoS One; 2013; 8(11):e78610. PubMed ID: 24223161
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: KODAMA exploratory analysis in metabolic phenotyping.
Zinga MM; Abdel-Shafy EA; Melak T; Vignoli A; Piazza S; Zerbini LF; Tenori L; Cacciatore S
Front Mol Biosci; 2023; 10():1165720. PubMed ID: 36968275
[TBL] [Abstract][Full Text] [Related]
11. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.
Yu GR; Qin WW; Li JP; Hua W; Meng YL; Chen R; Yan B; Wang L; Zhang X; Jia LT; Zhao J; Zhang R; Yang AG
Biosci Rep; 2012 Jun; 32(3):271-9. PubMed ID: 21679157
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Deciphering the mechanism of inhibition of SERCA1a by sarcolipin using molecular simulations.
Barbot T; Beswick V; Montigny C; Quiniou É; Jamin N; Mouawad L
Front Mol Biosci; 2022; 9():1035445. PubMed ID: 36310601
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Systematic analysis of MCM3 in pediatric medulloblastoma
Cao L; Zhao Y; Liang Z; Yang J; Wang J; Tian S; Wang Q; Wang B; Zhao H; Jiang F; Ma J
Front Mol Biosci; 2022; 9():1076243. PubMed ID: 36452454
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting.
Wen D; Gao Y; Ho C; Yu L; Zhang Y; Lyu G; Hu D; Li Q; Zhang Y
Front Mol Biosci; 2022; 9():894660. PubMed ID: 35573723
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.
Thomas RG; Surendran SP; Jeong YY
Front Mol Biosci; 2021; 8():693909. PubMed ID: 34026853
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation.
Liu S; Yang J; Sun G; Zhang Y; Cheng C; Xu J; Yen K; Lu T
Front Mol Biosci; 2022; 9():834509. PubMed ID: 35254346
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer.
Gan J; Meng Q; Li Y
Front Mol Biosci; 2021; 8():653454. PubMed ID: 33928124
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology.
Guo Y; Wang B; Gao H; Gao L; Hua R; Xu JD
Front Mol Biosci; 2022; 9():1063507. PubMed ID: 36339711
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Injecting Immunosuppressive M2 Macrophages Alleviates the Symptoms of Periodontitis in Mice.
Miao Y; He L; Qi X; Lin X
Front Mol Biosci; 2022; 9():848875. PubMed ID: 35146000
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Identification of novel thermosensors in gram-positive pathogens.
Fernández P; Díaz AR; Ré MF; Porrini L; de Mendoza D; Albanesi D; Mansilla MC
Front Mol Biosci; 2022; 9():1007054. PubMed ID: 36120544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
